|
|
0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
| Navn | Lysnes Invest AS |
|---|---|
| Orgnr/født år | 992910887 |
| Ant aksjer | 104,712 |
| Omsetning | 0 |
| Driftsresultat | -1,057 |
| Egenkapital | 160,177 |
| Ant.eiere | 2 |
| Navn | Orgnr/født år | Aksjeklasse | Ant aksjer | Andel |
|---|---|---|---|---|
| Ole-Kristian Nergård | 1992 | Ordinære aksjer | 100,000 | 95.5% |
| Lysnes Invest AS | 992910887 | Ordinære aksjer | 4,712 | 4.5% |
| Navn | Via | Ant aksjer | Andel | Egenkapital |
|---|---|---|---|---|
| Ole-Kristian Nergård | Lysnes Invest AS | 4,500 | 4.3% | 0 |
| Lysnes Invest AS | Lysnes Invest AS | 212 | 0.2% | 0 |
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Makarios AS | 95,600 | 95.6% | -21 | -1,608 | 5 | |
| Bergsfjorden Eiendom AS | 25 | 25.0% | 0 | -1 | 20 | 3 |
| Bad Bishop AS | 10,000 | 10.0% | 839 | 107 | 149 | 43 |
| Julius Caesar AS | 5,800 | 7.2% | 534 | 31 | 339 | 4 |
| Lysnes Invest AS | 4,712 | 4.5% | 0 | -48 | 7,208 | 2 |
| Eli AS | 2,737 | 1.7% | -2 | 49 | 5 | |
| Lytix Biopharma AS | 615,654 | 1.5% | 61 | -1,487 | 789 | 1,097 |
| Pharma Holdings AS | 8,807 | 0.9% | 15 | -131 | 142 | 291 |
| Pharmasum Therapeutics AS | 20,719 | 0.7% | 9 | -10 | 18 | 683 |
| Amicoat AS | 146,964 | 0.5% | 85 | -22 | 270 | 311 |
* Justert for eierandel
| Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
|---|---|---|---|---|---|---|
| Makarios AS
Via Lysnes Invest AS |
4,302 | 4.3% | -1 | -72 | 5 | |
| Luxhurray AS
Via Julius Caesar AS |
18,254 | 2.4% | 30 | -3 | -4 | 6 |
| Bergsfjorden Eiendom AS
Via Lysnes Invest AS |
1 | 1.1% | 0 | -0 | 1 | 3 |
| Bad Bishop AS
Via Lysnes Invest AS |
450 | 0.5% | 38 | 5 | 7 | 43 |
| Peptide Patents AS | 0 | 0.4% | 5 | -0 | 3 | 2 |
| Julius Caesar AS
Via Lysnes Invest AS |
261 | 0.3% | 24 | 1 | 15 | 4 |
| Peptide Patents AS
Via Amicoat AS |
0 | 0.2% | 3 | -0 | 2 | 2 |
| Lysnes Invest AS
Via Lysnes Invest AS |
212 | 0.2% | 0 | -2 | 324 | 2 |
| Observe Medical ASA
Via Eli AS |
191,381 | 0.1% | 3 | -19 | 357 | 2,124 |
| Eli AS
Via Lysnes Invest AS |
123 | 0.1% | -0 | 2 | 5 | |
| Lytix Biopharma AS
Via Lysnes Invest AS |
27,704 | 0.1% | 3 | -67 | 35 | 1,097 |
| Pharma Holdings AS
Via Lysnes Invest AS |
396 | 0.0% | 1 | -6 | 6 | 291 |
| Pharmasum Therapeutics AS
Via Lysnes Invest AS |
932 | 0.0% | 0 | -0 | 1 | 683 |
| Amicoat AS
Via Lysnes Invest AS |
6,613 | 0.0% | 4 | -1 | 12 | 311 |
| Pharmasum Therapeutics AS | 593 | 0.0% | 0 | -0 | 1 | 683 |
* Justert for eierandel
